{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:58:13Z","timestamp":1784743093946,"version":"3.55.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhongshan Social Welfare and Foundation Special Project","award":["2020B3004"],"award-info":[{"award-number":["2020B3004"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>With adequate serum concentration of antiepileptic drugs, the epilepsy symptoms in many patients still cannot be controlled well. The alteration of glycosyltransferase has obvious influence on the pathogenesis of epilepsy. In this study, we focus on the diagnostic and prognostic value of fucosyltransferase 8 (Fut8) on epilepsy and refractory epilepsy. Serum samples of 199 patients with epilepsy, 59 patients with refractory epilepsy and 22 healthy controls who were diagnosed in Shenzhen Children\u2019s hospital from August 2018 to August 2019 were collected. The level of lectins was further analyzed by lectin chip and enzyme linked immunosorbent assay (ELISA). The diagnostic value of serum Fut8 for epilepsy and refractory epilepsy was evaluated by receiver operating characteristic curve. Finally, the difference in the recurrence rate of convulsion in patients with epilepsy or refractory epilepsy within 2 years were observed in different Fut8 expression patients. The concentration of valproic acid (VPA) were significant different between epilepsy and refractory epilepsy group. The expression of \u03b11, 6-fucosylation and Fut8 was significantly increased in the refractory epilepsy group compared with healthy controls. The area under the curve of Fut8 as a biomarker for predicting epilepsy or refractory epilepsy was 0.620 and 0.856, respectively. There was a significant difference in the recurrence rate of convulsion within 2 years in the children with refractory epilepsy (<jats:italic>p<\/jats:italic> = 0.0493) not epilepsy (<jats:italic>p<\/jats:italic> = 0.1865) between the high and low Fut8 expression groups. Fut8 was one of the effective indicators for the diagnosis and prognosis of refractory epilepsy.<\/jats:p>","DOI":"10.1371\/journal.pone.0284239","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T17:47:18Z","timestamp":1681408038000},"page":"e0284239","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnosis and prognosis of serum Fut8 for epilepsy and refractory epilepsy in children"],"prefix":"10.1371","volume":"18","author":[{"given":"Yunxiu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-418X","authenticated-orcid":true,"given":"Linmu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"pone.0284239.ref001","doi-asserted-by":"crossref","first-page":"106327","DOI":"10.1016\/j.eplepsyres.2020.106327","article-title":"A review of the drug-drug interactions of the antiepileptic drug brivaracetam","volume":"163","author":"BD Moseley","year":"2020","journal-title":"Epilepsy research"},{"issue":"4","key":"pone.0284239.ref002","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"RS Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"2","key":"pone.0284239.ref003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/epd.2015.0736","article-title":"Incidence, prevalence and aetiology of seizures and epilepsy in children","volume":"17","author":"P Camfield","year":"2015","journal-title":"Epileptic disorders: international epilepsy journal with videotape"},{"issue":"2","key":"pone.0284239.ref004","first-page":"362","article-title":"Identification and Treatment of Drug-Resistant Epilepsy","volume":"25","author":"JY Yoo","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"issue":"8","key":"pone.0284239.ref005","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00415-017-8394-2","article-title":"Recent advances in epilepsy","volume":"264","author":"M. Manford","year":"2017","journal-title":"J Neurol"},{"issue":"7","key":"pone.0284239.ref006","first-page":"439","article-title":"Drug-resistant epilepsy: definition and treatment alternatives","volume":"30","author":"FJ Lopez Gonzalez","year":"2015","journal-title":"Neurologia"},{"issue":"10","key":"pone.0284239.ref007","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences","volume":"17","author":"M Romoli","year":"2019","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"pone.0284239.ref008","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00228-018-2444-2","article-title":"A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsy","volume":"74","author":"C Rodrigues","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"pone.0284239.ref009","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-4939-7389-7_16","article-title":"Analysis of Protein Glycosylation in the ER","volume":"1691","author":"J Schoberer","year":"2018","journal-title":"Methods in molecular biology"},{"issue":"3","key":"pone.0284239.ref010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jimd.12055","article-title":"Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients","volume":"42","author":"MA Vals","year":"2019","journal-title":"Journal of inherited metabolic disease"},{"issue":"1","key":"pone.0284239.ref011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10719-012-9390-5","article-title":"\"Casting\" light on the role of glycosylation during embryonic development: insights from zebrafish","volume":"30","author":"HR Flanagan-Steet","year":"2013","journal-title":"Glycoconjugate journal"},{"issue":"34","key":"pone.0284239.ref012","first-page":"8207","article-title":"Acute Increases in Protein O-GlcNAcylation Dampen Epileptiform Activity in Hippocampus. The Journal of neuroscience: the official journal of the","volume":"37","author":"LT Stewart","year":"2017","journal-title":"Society for Neuroscience"},{"issue":"1","key":"pone.0284239.ref013","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010076","article-title":"Anticonvulsant Activity of Halogen-Substituted Cinnamic Acid Derivatives and Their Effects on Glycosylation of PTZ-Induced Chronic Epilepsy in Mice","volume":"23","author":"Y Cuan","year":"2017","journal-title":"Molecules"},{"issue":"3","key":"pone.0284239.ref014","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/19336950.2016.1138189","article-title":"Modulation of Cav3.2 T-type calcium channel permeability by asparagine-linked glycosylation","volume":"10","author":"K Ondacova","year":"2016","journal-title":"Channels"},{"key":"pone.0284239.ref015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.placenta.2018.11.005","article-title":"FUT8 drives the proliferation and invasion of trophoblastic cells via IGF-1\/IGF-1R signaling pathway","volume":"75","author":"M Yu","year":"2019","journal-title":"Placenta"},{"key":"pone.0284239.ref016","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2019.09.001","article-title":"Lysophosphatidic acid decreased macrophage foam cell migration correlated with downregulation of fucosyltransferase 8 via HNF1alpha","volume":"290","author":"L Chen","year":"2019","journal-title":"Atherosclerosis"},{"issue":"4","key":"pone.0284239.ref017","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jimd.12221","article-title":"Expanding the molecular and clinical phenotypes of FUT8-CDG","volume":"43","author":"BG Ng","year":"2020","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"pone.0284239.ref018","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ajhg.2017.12.009","article-title":"Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation","volume":"102","author":"BG Ng","year":"2018","journal-title":"Am J Hum Genet"},{"key":"pone.0284239.ref019","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.3233\/JRS-150679","article-title":"Safety and efficacy of valproic acid preparations","volume":"271","author":"E Pasternak","year":"2015","journal-title":"Int J Risk Saf Med"},{"issue":"15","key":"pone.0284239.ref020","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"RM Nanau","year":"2013","journal-title":"Clinical biochemistry"},{"key":"pone.0284239.ref021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-neuro-071714-034019","article-title":"Neurological aspects of human glycosylation disorders","volume":"38","author":"HH Freeze","year":"2015","journal-title":"Annu Rev Neurosci"},{"key":"pone.0284239.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci11010088","article-title":"Congenital Disorders of Glycosylation from a Neurological Perspective","volume":"11","author":"J Paprocka","year":"2021","journal-title":"Brain Sci"},{"issue":"21","key":"pone.0284239.ref023","doi-asserted-by":"crossref","first-page":"18434","DOI":"10.1074\/jbc.M110.172536","article-title":"Alpha1,6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: importance of the balance between the dopamine and serotonin systems","volume":"286","author":"T Fukuda","year":"2011","journal-title":"J Biol Chem"},{"issue":"4","key":"pone.0284239.ref024","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12040527","article-title":"Prospective Evaluation of Ghrelin and Des-Acyl Ghrelin Plasma Levels in Children with Newly Diagnosed Epilepsy: Evidence for Reduced Ghrelin-to-Des-Acyl Ghrelin Ratio in Generalized Epilepsies","volume":"12","author":"AM Costa","year":"2022","journal-title":"J Pers Med"},{"issue":"12","key":"pone.0284239.ref025","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1177\/0883073807307096","article-title":"The role of ghrelin in weight gain and growth in epileptic children using valproate","volume":"22","author":"S Gungor","year":"2007","journal-title":"J Child Neurol"},{"issue":"6\u20137","key":"pone.0284239.ref026","first-page":"609","article-title":"[Reticular and Golgi glycosylation: Advances and associated diseases]","volume":"37","author":"S Groux-Degroote","year":"2021","journal-title":"Med Sci (Paris)"},{"issue":"1","key":"pone.0284239.ref027","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41419-020-03314-y","article-title":"Structure, function, and pathology of protein O-glucosyltransferases","volume":"12","author":"MZ Mehboob","year":"2021","journal-title":"Cell Death Dis"},{"issue":"7681","key":"pone.0284239.ref028","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature24464","article-title":"Structural basis of nucleotide sugar transport across the Golgi membrane","volume":"551","author":"JL Parker","year":"2017","journal-title":"Nature"},{"issue":"Suppl 2","key":"pone.0284239.ref029","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/epi.12182","article-title":"The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs","volume":"54","author":"MA Rogawski","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"pone.0284239.ref030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2990.2005.00699.x","article-title":"Vascular colocalization of P-glycoprotein, multidrug-resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies","volume":"32","author":"SM Sisodiya","year":"2006","journal-title":"Neuropathology and applied neurobiology"},{"issue":"Pt 1","key":"pone.0284239.ref031","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awh682","article-title":"Molecular and cellular mechanisms of pharmacoresistance in epilepsy","volume":"129","author":"S Remy","year":"2006","journal-title":"Brain: a journal of neurology"},{"issue":"1","key":"pone.0284239.ref032","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1179\/174313209X408954","article-title":"Drug transporters are altered in brain, liver and kidney of rats with chronic epilepsy induced by lithium-pilocarpine","volume":"32","author":"Y Guo","year":"2010","journal-title":"Neurological research"},{"issue":"8","key":"pone.0284239.ref033","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.neuropharm.2008.08.032","article-title":"Several major antiepileptic drugs are substrates for human P-glycoprotein","volume":"55","author":"C Luna-Tortos","year":"2008","journal-title":"Neuropharmacology"},{"issue":"10","key":"pone.0284239.ref034","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1528-1167.2011.03140.x","article-title":"In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein","volume":"52","author":"C Zhang","year":"2011","journal-title":"Epilepsia"},{"key":"pone.0284239.ref035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eplepsyres.2018.09.008","article-title":"High incidence of persistent subtherapeutic levels of the most common AEDs in children with epilepsy receiving polytherapy","volume":"148","author":"L Czornyj","year":"2018","journal-title":"Epilepsy research"},{"issue":"10","key":"pone.0284239.ref036","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.1016\/S0021-9258(18)53199-9","article-title":"N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein","volume":"268","author":"AH Schinkel","year":"1993","journal-title":"The Journal of biological chemistry"},{"issue":"49","key":"pone.0284239.ref037","doi-asserted-by":"crossref","first-page":"32373","DOI":"10.1074\/jbc.273.49.32373","article-title":"Quality control by proteases in the endoplasmic reticulum. Removal of a protease-sensitive site enhances expression of human P-glycoprotein","volume":"273","author":"TW Loo","year":"1998","journal-title":"The Journal of biological chemistry"},{"issue":"Suppl 5","key":"pone.0284239.ref038","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1167.2007.01302.x","article-title":"ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy","volume":"48","author":"A Lazarowski","year":"2007","journal-title":"Epilepsia"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T17:47:51Z","timestamp":1681408071000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284239"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Biagini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0284239","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]}}}